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Summary: Using five procedures (turbidimetry with the Boehringer Mannheim kit and with a home made reagent,
Teflectometry with the Eastman Kodak kit, colorimetry with the Sigma kit, and UV spectrophotometry with the
Wako kit), lipase activity was assayed in the same group of 60 healthy adults and in 30 patients suffering from
acute pancreatitis (n = 197 samples) äs well äs in a purified and stabilized preparation of human pancreatic lipase.
Results indicated considerable inter-assay discrepancies for the mean values of the patients' results: catalytic activity
concentrations differed by a factor of up to 16 according to the measurement procedures. For each method, mean
i" patients' results were also expressed äs multiples of the upper limit of normal values. This method of presentation
| did not sigriificantly improve the intra-assay agreement, with maximal relative differences äs high äs 13-fold. When
j each method was calibrated with the same material (human pancreatic lipase), the inter-assay agreement was
!' considerably improved. The causes of inter-assay disagreement are discussed in detail, and the necessity for a
' validated lipase calibrator is stressed, in order to improve the efficiency of the information transmitted by clinical
laboratories to clinicians. A stfategy is proposed, which includes development of a reference method and reference
\ material, and a study of inter-assay commutability of secondary calibrators for a set of methods.
Introduction In this study, our goal was to:
Pancreatic lipase (E.G. 3.1.1.3, triacylglycerol acylhyd- ~ compare the reaction conditions of the methods of
rolase) is often considered to be a more sensitive and measurement commonly used in clinical laboratories
specific maricer than c^amylase and pancreatic isoamyl- and to see if they Mf[l requirements for the specific
äse for the diagnosis of acute pancreatitis (1-4). How- determination of pancreatic lipase activity;
ever, discrepancies in the reported data are frequent and - compare the results of plasma lipase activity in
may have at least three causes. The selection of patient patients suffering from acute pancreatitis with regard to
populations, particularly with regard to the prevalence the analyticai procedures;
of acute pancreatitis and the retained criteria for the di- _
 eya,uate ^  advantage of a proper lipase calibrator
agnosis of acute paricreatitis differ from one study to
 for Ae improvement pf the interassay agreement of re-
another (5-6). Furthermore, the chosea deeision limit
 sult§ transmitted to the clinicians.
for lipase activity varies considerably between studies
(3, 6, 7). Finally, rputine methods used for the measure-
ment of serurn lipase activity involve turbidimetric, re- Materials and Methods
flectometric, and visibie or UV spectrophotometric tech-
 Table 1shows the flve methods used in lhis sludy All the assays
niques, differing from one Study to another. utilize dotergents (most often biie salts) at supramiccllar concen-
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trations, thereby reducing the lag phase and inhibiting all the lipo-
lytic activities. The deoxycholate concentration varies between 6.6
and 19 mmol/1. The Eastman Kodak reagent contains dodecyl ben-
zene sulphonate instead of a bile salt. Colipase, added in excess,
specifically reverses this Inhibition and induces a considerable acti-
vation of the enzyrae. One or two divalent cations (Ca2+, Mg2*)
are always added in these modern methods. The pH of the reaction
media varies from 7.2 to 9.2. AJ1 the procedures can be automated
and the reaction can be continuously monitored, except for the
reflectometric test. Most of the lipase assays are indirect in the
sense that they do not determine the number of ester bonds hydro-
lysed per time unit (13), unlike the titrimetric procedures defived
from the Cherry & Crandall method (14). For this reason, indirect
methods are often calibrated with the help of an enzyme Standard
prepared from human or porcine pancreas. In the present study, a
purified stable human pancreatic lipase was also used for inter-
assay comparison (15).
Blood samples from 30 patients suffering from acute pancreatitis
were collected on lithium heparinate, and 197 plasma samples were
assayed for lipase activity by five methods on the same apparatus
(Cobas Fara, Röche) at 30 °C, except for the reflectometric tech-
nique which was performed at 37 °C on an Ektachem 700. Plasma
samples were also obtained from 60 apparently healthy adults (30
men and 30 women) aged 20—60 years, and the reference values
of plasma lipase activity were established for each method. For the
four commercialized reagents, manufacfurer's recommendations
were followed without modiflcation.
The mean and Standard deviations (SD) of the five series of results
were calculated for healthy and patient groups. For healthy adults,
intervals corresponding to mean ± 2 SD were considered äs the
reference ranges of lipase activity concentrations in plasma.
Results
In our hands, all the procedures were easy to perform,
could be adapted to emergency situations, and were re-
producible. Nevertheless, the UV spectrophotometric as-
say (Wako) was less precise in terms of interserial repro-
ducibility. Furthermore, ratiges of linearity vary con-
siderably from 5 times the upper limit of reference va-
lues (Boehringer Mannheim) to more than 100 times
(Sigma).
Figure l a shows a typical example of patterns observed
for a patient sufifering from acüte pancreatitis with a
favourable evplution. Values attained a peak during the
observation period, but the actual values varied greatly
depending on the methods. When the activity concen-
trations were divided by the upper limit of reference
values (fig. Ib), values still displäyed considerable dif-
ferences, depending on the method of measurement.
When the mean values of lipase activity cpnceütrations
of all patients' samples were considered (tab. 2), we
noted that they differed by a faetor of-up to 16 according
to the method used, but the results were strongly corre-
lated (0.95 < r < 0.98). For each of the 30 patients stud-
ied, the maximum of lipase activity was observed at the
same time for each method of measurement. At this
time, the activity concentrations were always in the
satne order: Wako < Sigma < home made reagent <
Boehringer < Kodak. When patients' results were ex-
5000
Fig. l Plasma of a patient diagnosed äs having acute pancreatitis
was assayed for lipase activity over several days, using five dif-
ferent procedures (A Eastman Kodak reagent; D Boehringer Mann-
heim reagent; D Home made reagent; o Sigma reagent; O Wako
reagent, see Materials and Methods). Results are expressed in U/l
(flg. l a) and in multiples of the upper limit of reference values
(fig. Ib).
Tab. 2 Comparison of three modes of expression of lipase activ-
ity.
For each method, the results are expressed in catalytic activity con-
centrations (mean value ± Standard deviation), in multiples of the
upper limit of reference values and the activity relative to that de-
termined in a purified preparation of pancreatic lipase.
Reagent Lipase
Boehringer
Mannheim
Home made
reagent
Eastman
Kodak
Sigma
Wako
Catalytic
activity
concentration
[U/l]
765 ± 602
420 ± 4J2
1516 ± 1089
294 ± 202
92 ± 82
Multiples of
the upper
limit of
reference
values
5.2
23.3
19.4
21.0
1.8
Activity
relative to
purified
enzyme
1.17
0.84
0.93
1.18
1.00
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prcssed äs multiples of the upper limit of reference va-
lues, they still differed (by äs much äs 13-fold), but they
vvere in a different order (Wako < Boehringer < Kodak
< Sigma < home made reagent). By using a purified
and stabilized preparation of human pancreatic lipase
(15) äs a Standard, it was possible to compare the results
obtained with the five methods. As shown in table 2,
when the reaction rate observed with the purified prep-
aration was assigned a value of 1.0 for each method, the
inter-assay agreement was considerably improved; the
lipase activity by different methods then varied by a fac-
tor of l to 1.4. Each method was not calibrated with
the commercial Standards for the diiferent procedures,
because inter-method discrepancies were found to be
higher for these materials than for patient samples (not
shown).
Discussion
Several röutine methods are suitable for the assay of
lipase activity in emergency situations in terms of pre-
cision, rapidity and practicability. Nevertheless, con-
siderabie inter-assay discrepancies were observed in the
degree of increase in the plasma lipase activity. They
were not due to inaccuracies in the temperature or vol-
ume settings, since the same apparatus was used for per-
forming four of the five tested methods, and four pro-
cedures employed a calibrator. Similarly, differences in
the selection of healthy subjects cannot explain inter-
assay disagreement, since samples from the same äppar-
ently healthy subjects were retained to establish refer-
ence ranges for the five methods.
There are several possible reasons for these discrepanc-
ies, involving the calibration procedures and the analyti-
cal specificity of the methods. The enzyme calibrators
should exhibit the same catalytic properties äs the en-
zyme determined in human samples; this is not always
the case (9), especially with regard to the requirements
for effectors, and thermodependance. As most of the
tested methods use different calibrators, inter-method
discrepancy may be due to differences in the origin of
the calibrator, and to effects of different procedures for
the purification and stabilization of the calibrator en-
zyme, äs well äs the chosen matrix. All these variables
might affect the catalytic properties of calibrators, and
lead to the observed inter-assay discrepancies. More-
over, the calibrators proposed by the manufacturers are
not titrated against the same reference method. The ref-
erence procedures also differ with respect to several va-
riables such äs temperature, Substrate concentration,
mode of emulsification of the Substrate, type and con-
centration of the added bile salt, and supplementation
with colipase (16, 17).
This study also shows that strong correlations between
different assays do not necessarily mean that the con-
sidered assays exhibit identicai analytical specificities.
This is clearly illustrated by the great discrepancies ob-
served when patients' results are expressed äs multiples
of the upper limit of the reference ranges. In fact, the
validity of this approach depends ön-an identicai speci-
ficity of the compared methods with regard to the
plasma lipolytic activities from healthy subjects and
patients. Obviously, this requirement was not fulfilled
for all the tested methods of measurement. Several au-
thors have pointed out that various enzymes may inter-
fere in some assays (6, 18, 19). Differences in the nature
of the Substrate (1,2-diacylglycerol, asymmetric or
homogeneous triacylglycerol), the size of micelles and
the type of detergent may affect analytical specificity.
Furthermore, different fonns of pancreatic lipase, at least
two, have been observed in plasma samples of patients
suffering from acute pancreatitis (20, 21). The profile of
pancreatic lipase isoforms, which is not the same in
healthy subjects and in cases of acute pancreatitis, may
be a source of inter-assay disagreement (20„ 21). We
also have to keep in mind that different cut-off values
were used when eomparative studies were perforaied to
evaluate the efficiency of lipase for the diagnosis of
acute pancreatitis. These cut-offs varied from one to nine
when lipase activities were expressed in multiples of the
upper limit of the reference ranges (5, 6).
Conclusion
Lipase provides an interesting Illustration of some gene^
ral features of clinical enzymology. As for all catalytic
activities, results are method dependent, but differences
are much more marked for lipase than for other enzymes
wheri results are expressed in catalytic concentrations
(U/l). At present, the consensus for the use of an excess
of a detergent and of colipase is not sufficient to ensure
inter-assay agreement. One pecularity of lipase assays in
clinical enzymology is the use of calibrators in most of
the kits. If a calibration procedure is used to reduce the
effect of drift on the results, it can also be a source of
inaccuracy, if its catalytic properties are not the same äs
those of human enzyme. Moreover, there is not yet a
reference method for the determinatipm of lipase activity.
Based on the results of the present stüdy, we propose
here a strategy to improve the efipcieney, of Information
transmitted to clinicans. The first step is the develop-
ment of a reference method and of ä lipase reference
material exhibiting the same catalytic properties äs the
plasma "pancreatitis" lipase. The second step is the cer-
tification of the reference material by the referemee me-
thod. Then, röutine methods hacwe to -be tested against the
Eur. J. Clin. Chem, Clin. Biochem. / Vol. 32. 1994 / No. 5
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; reference method, by assaying a series of both patients'
, samples and the reference material in order to verify
commutability of the latter product. Commutability re-
! fers to the ability of an enzyme material to show inter-
! assay activity changes comparable to those of the same
enzyme in human plasma (22). If commutability of the
reference material with patients' samples is observed for
a given set of methods, reference and routine methods
will show similar accuracy, and there will be inter-assay
agreement with the reference method. Moreover, the ref-
erence material can be used for the selection of second-
ary calibrators by verifying that the inter-method ratio
of activity is the same for secondary materials äs for
the reference preparation. Furthermore, in such a set of
methods, the reference material, titrated against the ref-
erence method, could be employed to assign values to
secondary calibrators. Obviously, other sets of methods
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